Stocks · Health care · Pharmaceutical Preparations

ARS Pharmaceuticals, Inc.

SPRY Clue Score36
United States Fiscal year ends December CIK 0001671858 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Richard E Lowenthal
6 Dec 2024
President and CEO
Exercised, kept indirect
11,876
$8.42
$100.00K
Richard E Lowenthal
6 Dec 2024
President and CEO
Exercised, kept indirect
13,789
$1.44
$19.86K
Richard E Lowenthal
6 Dec 2024
President and CEO
Exercised, kept
11,876
$8.42
$100.00K
Sarina Tanimoto
6 Dec 2024
Chief Medical Officer
Exercised, kept indirect
11,876
$8.42
$100.00K
Sarina Tanimoto
6 Dec 2024
Chief Medical Officer
Exercised, kept
11,876
$8.42
$100.00K
Sarina Tanimoto
6 Dec 2024
Chief Medical Officer
Exercised, kept
13,789
$1.44
$19.86K
Richard E Lowenthal
23 Apr 2024
President and CEO
Exercised, kept indirect
48,260
$1.44
$69.49K
Richard E Lowenthal
23 Apr 2024
President and CEO
Exercised, kept indirect
82,733
$0.84
$69.50K
Sarina Tanimoto
23 Apr 2024
Chief Medical Officer
Exercised, kept
48,260
$1.44
$69.49K
Sarina Tanimoto
23 Apr 2024
Chief Medical Officer
Exercised, kept
82,733
$0.84
$69.50K
Richard E Lowenthal
19 Apr 2024
President and CEO
Exercised, kept
69,444
$1.44
$100.00K
Richard E Lowenthal
19 Apr 2024
President and CEO
Exercised, kept
119,047
$0.84
$100.00K
Sarina Tanimoto
19 Apr 2024
Chief Medical Officer
Exercised, kept indirect
69,444
$1.44
$100.00K
Sarina Tanimoto
19 Apr 2024
Chief Medical Officer
Exercised, kept indirect
119,047
$0.84
$100.00K
Laura Shawver
5 Aug 2022
Chief Executive Officer
Exercised, kept
78,740
$1.27
$100.00K
Showing 250 of 261 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 231
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 149
Sales straight out of an exercise 51
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 84,407,624
History held since 7 Dec 2020